6-KThe Wire
Alvotech files 6-K
Filed Jan 29, 2026 · 5mo ago · Accession 0001171843-26-000504
Plain English
Alvotech announced a licensing and settlement agreement with Regeneron and Bayer on January 29, 2026, resolving all worldwide patent disputes concerning its biosimilar to Eylea® 2mg (aflibercept 40 mg/mL solution).
Filing details
- Company
- Alvotech
- Ticker
- ALVO
- CIK
- 1898416
- Form type
- 6-K
- Filing date
- Jan 29, 2026
- Report date
- Jan 29, 2026
- Document
- f6k_012826.htm
- Size
- 17 KB